97 related articles for article (PubMed ID: 6428770)
1. Striatal dopamine-stimulated adenylate cyclase activity reflects susceptibility of rats to 7,12-dimethylbenz[a]anthracene-induced mammary tumor development.
Goldman PR; Vogel WH
Carcinogenesis; 1984 Jul; 5(7):971-3. PubMed ID: 6428770
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cyclic adenosine 3',5'-monophosphate in relation to growth of dimethylbenz[a]anthracene-induced mammary tumors in rats.
Ip C; Dao TL
Cancer Lett; 1980 Jan; 8(3):227-33. PubMed ID: 6261941
[TBL] [Abstract][Full Text] [Related]
3. Anticarcinogenic effect of N6,O2'-dibutyryl cyclic adenosine 3':5'-monophosphate on 7,12-dimethylbenz(a)anthracene mammary tumor induction in the rat and its relationship to cyclic adenosine 3':5'-monophosphate metabolism and protein kinase.
Cho-Chung YS; Clair T; Shepheard C
Cancer Res; 1983 Jun; 43(6):2736-40. PubMed ID: 6303567
[TBL] [Abstract][Full Text] [Related]
4. Restraint-induced inhibition of 7,12-dimethylbenz[a]anthracene-induced mammary tumors: relation to stages of tumor development.
Newberry BH
J Natl Cancer Inst; 1978 Sep; 61(3):725-9. PubMed ID: 99522
[TBL] [Abstract][Full Text] [Related]
5. Plasma estradiol and prolactin levels and their response to stress in two strains of rat with different sensitivities to 7,12-dimethylbenz[a]anthracene-induced tumors.
Goldman PR; Vogel WH
Cancer Lett; 1985 Jan; 25(3):277-82. PubMed ID: 3918785
[TBL] [Abstract][Full Text] [Related]
6. Serum poly(A)polymerase levels in rats during induction of mammary carcinoma with 7,12-dimethylbenz[a]anthracene.
Barsoum AL; Kurl RN
Cancer Lett; 1991 Jul; 58(3):195-7. PubMed ID: 1906776
[TBL] [Abstract][Full Text] [Related]
7. Topographical distribution of dimethylbenz(a)anthracene-induced rat mammary tumors.
Kellen JA
Ann Clin Lab Sci; 1983; 13(4):289-90. PubMed ID: 6414359
[TBL] [Abstract][Full Text] [Related]
8. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea.
VanderPloeg LC; Wolfrom DM; Welsch CW
Cancer Res; 1991 Jul; 51(13):3399-404. PubMed ID: 1905195
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate.
el-Bayoumy K; Chae YH; Upadhyaya P; Meschter C; Cohen LA; Reddy BS
Cancer Res; 1992 May; 52(9):2402-7. PubMed ID: 1568209
[TBL] [Abstract][Full Text] [Related]
10. Effect of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis on the opioid peptide levels in the rat central nervous system.
Vaswani KK; Tejwani GA; Abou-Issa HM
Cancer Lett; 1986 May; 31(2):115-22. PubMed ID: 2870795
[TBL] [Abstract][Full Text] [Related]
11. Facilitation of dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by restraint stress: role of beta-endorphin, prolactin and naltrexone.
Tejwani GA; Gudehithlu KP; Hanissian SH; Gienapp IE; Whitacre CC; Malarkey WB
Carcinogenesis; 1991 Apr; 12(4):637-41. PubMed ID: 1901524
[TBL] [Abstract][Full Text] [Related]
12. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory action of Piper betle on the initiation of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in rats.
Rao AR; Sinha A; Selvan RS
Cancer Lett; 1985 Mar; 26(2):207-14. PubMed ID: 3919938
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine and hydergine: a comparison on striatal or hypothalamic adenylate cyclase activity.
Portaleone P
Pharmacology; 1978; 16 Suppl 1():207-9. PubMed ID: 643903
[TBL] [Abstract][Full Text] [Related]
15. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-dependent plasminogen activator in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors in vivo and in vitro.
Yamashita J; Horiuchi S; Shigaki N; Fujino N; Akagi M
Gan; 1984 Aug; 75(8):681-9. PubMed ID: 6436130
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone receptor levels in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors in each week--check points about experimental studies using DMBA-induced tumors.
Iino Y; Izuo M; Horiuchi R
Jpn J Exp Med; 1990 Dec; 60(6):351-4. PubMed ID: 2128946
[No Abstract] [Full Text] [Related]
18. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
Thun-Battersby S; Mevissen M; Löscher W
Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
[TBL] [Abstract][Full Text] [Related]
19. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin.
Verma AK; Johnson JA; Gould MN; Tanner MA
Cancer Res; 1988 Oct; 48(20):5754-8. PubMed ID: 3139283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
